Naltrexone [ReVia] will be fully funded by New Zealand's drug-funding agency, Pharmac, from 1 June 2004, for patients with alcoholism.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 453, 2004-05-22 , pp. 11-11(1)

Publisher: Adis International

Keywords: Alcoholism, treatment; Naltrexone, therapeutic use; Reimbursement

Document Type: Short communication

Publication date: 2004-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers